Clinical trial

Comparison of Cryoablation of Intercostal Nerves to Erector Spinae Plane Catheters in Patients With Rib Fractures

Name
ANES-2024-32820
Description
The purpose of this study is to determine if patients with rib fractures who undergo cryoablation of the intercostal nerves have improved pain control 7 days from procedure when compared to those who have a ESP catheter.
Trial arms
Trial start
2024-07-01
Estimated PCD
2026-07-31
Trial end
2027-01-30
Status
Not yet recruiting
Phase
Early phase I
Treatment
Cryoablation
an injection of 1ml of 1% lidocaine per rib and ultrasound guided cryoablation of the intercostal nerves
Arms:
Cryoablation
ESP Catheter
an ultrasound guided erector spinae plane catheter with initial bolus of 30 mL of 0.25% bupivacaine followed by infusion of 0.2% ropivacaine at 10 mL per hour via programmed intermittent bolus.
Arms:
ESP catheter
Size
48
Primary endpoint
Maximum pain score on POD (Post Operative Day) 7
7 days post procedure
Opioid Use
30 days post procedure
Functional Pain Scores
30 days post procedure
Number of Patients using opioids at POD 30
30 days post procedure
Length of hospital stay
30 days post procedure
Number of patients returned home by POD 30
30 days post procedure
time to first ambulation
30 days post procedure
number of patients admitted to ICU
30 days post procedure
number of patients that required mechanical ventilation
30 days post procedure
Pulmonary Function Testing.
30 days post procedure
Eligibility criteria
Inclusion Criteria: * Patients who are over 18 who have more than one ribs fractured. Exclusion Criteria: * Patients who have an exclusion to regional anesthesia. * Patients who are pregnant via self-report or pregnancy test if they take one. * Non-English speakers * Patients who have cold urticaria * Patients with bilateral fractures * Patients currently intubated
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'This is a randomized prospective controlled trial. This will be single blinded trial. The individual doing the outcome assessments will be blinded. Randomization will be 1:1.', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'SINGLE', 'maskingDescription': 'The individual doing the outcome assessments will be blinded.', 'whoMasked': ['OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 48, 'type': 'ESTIMATED'}}
Updated at
2024-05-30

1 organization

2 products

1 indication

Indication
Rib Fractures